Buschke-Löwenstein tumor of the vulva: case report and review of literature
Pyramid Journal of Medicine · 08.05.2026 · 9 (1)
DOI: 10.4081/pjm.2026.540 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pyramid Journal of Medicine, online erschienen am 08.05.2026. Verfasst von Hanifah D. Abubakar und 1 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Human papillomavirus is a common sexually transmissible infection, often asymptomatic. Where it does present with symptoms, they range from self-limiting anogenital warts (in low-risk subtypes) to malignant transformation (in high-risk subtypes). In extremely rare circumstances, anogenital warts can progress to become giant condyloma acuminata, a condition known as Buschke-Löwenstein Tumor (BLT). BLT is a slow-growing locally aggressive, cauliflower-like benign tumor, with a tendency to malignant transformation. In some instances, it could co-exist with atypical epithelial cells or a well-differentiated squamous cell carcinoma. This tumor is usually resistant to conventional medical therapy for anogenital warts. Surgical resection is often the treatment modality, the extent of which depends on the extent of the lesion We report a case of giant vulvar warts in a 17-year-old girl, who was successfully treated with skinning vulvectomy.
Zitieren
APA
Abubakar, H. D., & Bunawa, A. A. (2026). Buschke-Löwenstein tumor of the vulva: case report and review of literature. Pyramid Journal of Medicine, 9(1). https://doi.org/10.4081/pjm.2026.540
Vancouver
Abubakar HD, Bunawa AA. Buschke-Löwenstein tumor of the vulva: case report and review of literature. Pyramid Journal of Medicine. 2026;9(1). doi:10.4081/pjm.2026.540
BibTeX
@article{Abubakar2026,
author = {Abubakar, Hanifah D. and Bunawa, Abdulrahman A.},
title = {Buschke-Löwenstein tumor of the vulva: case report and review of literature},
journal = {Pyramid Journal of Medicine},
year = {2026},
volume = {9},
number = {1},
doi = {10.4081/pjm.2026.540}
}
EUVIMED